Anticancer Drug Docetaxel in Hospital Effluent: Development of Chromatographic Method, Occurrence, and Degradation via Ozonation

Anticancer agents, specifically designed to induce cell death in neoplastic cells, have become increasingly prevalent contaminants in various environmental matrices. Their extensive use has resulted in their detection across multiple settings, including hospital and pharmaceutical factory effluents, domestic wastewater, and surface waters. This study aimed to develop an analytical method for determining docetaxel residues in hospital effluent using Solid-Phase Extraction (SPE) and HPLC-DAD. The SPE method demonstrated R² greater than 0.99, with recovery rates reaching 95% and an RSD of less than 2%. The LOQ was established at 10.0 μg L−1, with no significant matrix effects observed for docetaxel. The validated SPE method was deemed suitable for its intended application, as all evaluated parameters met the specifications outlined in current regulatory guidelines. Docetaxel was quantified at 29.9 μg L−1 (±1.3%) in one of the 14 effluent samples collected over a week from the Federal University of Santa Maria Hospital (HUSM). Given that the microbiological treatment system at HUSM does not effectively remove this drug, an advanced degradation process using ozonation was investigated. A Dispersive Liquid-Liquid Microextraction (DLLME) method was developed for bench-scale degradation studies and subsequently applied to assess the degradation of docetaxel via ozonation in real samples. The optimized extraction conditions for docetaxel involved a 10 mL hospital effluent sample at pH 9, with ionic strength adjusted using Na₂SO₄. Methanol served as the disperser solvent, while chloroform was the extracting solvent. The ozonation process achieved a removal efficiency exceeding 97% after 60 minutes of reaction, under optimal conditions of pH 7 and an average ozone production rate of 1.5 g O₃ h⁻¹. These findings indicate that ozonation is an effective treatment strategy, significantly reducing docetaxel concentrations in hospital effluent within a short reaction timeframe.

Authors

Publication Details

Journal
Brazilian Journal of Analytical Chemistry
Published
2025-01-10
DOI
https://doi.org/10.30744/brjac.2179-3425.ar-134-2024
Primary Topic
Safe Handling of Antineoplastic Drugs
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anticancer Drug Docetaxel in Hospital Effluent: Development of Chromatographic Method, Occurrence, and Degradation via Ozonation

Ayrton F. Martins, Darliana Mello Souza, Nátalie de Paula, Júlia A. de Oliveira et al.
Brazilian Journal of Analytical Chemistry
Safe Handling of Antineoplastic Drugs
article

Anticancer Drug Docetaxel in Hospital Effluent: Development of Chromatographic Method, Occurrence, and Degradation via Ozonation

Ayrton F. Martins, Darliana Mello Souza, Nátalie de Paula, Júlia A. de Oliveira, J Reichert
article en

Abstract

Anticancer agents, specifically designed to induce cell death in neoplastic cells, have become increasingly prevalent contaminants in various environmental matrices. Their extensive use has resulted in their detection across multiple settings, including hospital and pharmaceutical factory effluents, domestic wastewater, and surface waters. This study aimed to develop an analytical method for determining docetaxel residues in hospital effluent using Solid-Phase Extraction (SPE) and HPLC-DAD. The SPE method demonstrated R² greater than 0.99, with recovery rates reaching 95% and an RSD of less than 2%. The LOQ was established at 10.0 μg L−1, with no significant matrix effects observed for docetaxel. The validated SPE method was deemed suitable for its intended application, as all evaluated parameters met the specifications outlined in current regulatory guidelines. Docetaxel was quantified at 29.9 μg L−1 (±1.3%) in one of the 14 effluent samples collected over a week from the Federal University of Santa Maria Hospital (HUSM). Given that the microbiological treatment system at HUSM does not effectively remove this drug, an advanced degradation process using ozonation was investigated. A Dispersive Liquid-Liquid Microextraction (DLLME) method was developed for bench-scale degradation studies and subsequently applied to assess the degradation of docetaxel via ozonation in real samples. The optimized extraction conditions for docetaxel involved a 10 mL hospital effluent sample at pH 9, with ionic strength adjusted using Na₂SO₄. Methanol served as the disperser solvent, while chloroform was the extracting solvent. The ozonation process achieved a removal efficiency exceeding 97% after 60 minutes of reaction, under optimal conditions of pH 7 and an average ozone production rate of 1.5 g O₃ h⁻¹. These findings indicate that ozonation is an effective treatment strategy, significantly reducing docetaxel concentrations in hospital effluent within a short reaction timeframe.

Brazilian Journal of Analytical Chemistry
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
Clean water and sanitation
Openalex Percentile: Top 99%
Safe Handling of Antineoplastic Drugs
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anticancer Drug Docetaxel in Hospital Effluent: Development of Chromatographic Method, Occurrence, and Degradation via Ozonation — Ayrton F. Martins, Darliana Mello Souza, et al. · Brazilian Journal of Analytical Chemistry (2025) | TGRS Research Map | TGRS